Suven Pharmaceuticals

Stocks to Watch Today: Bharti Airtel, Kfin Technologies, Nazara Tech, Dabur, Blue Star, Voltas, Symphony, United Breweries, Coal India in focus on 8 May

Stocks to Watch, 08 May: Stocks like Tata Chemicals, Mangalore Chemicals and Fertilizers, Sonata Software, Satin Creditcare Network, Somany Ceramics, Niva Bupa Health Insurance Company, Kfin Technologies, Astral, Mahindra and Mahindra, Suven Pharmaceuticals, and Vodafone Idea will be in focus on May 8.

Buy Suven Pharmaceuticals; target of Rs 1400: ICICI Securities

ICICI Securities is bullish on Suven Pharmaceuticals recommended buy rating on the stock with a target price of Rs 1400 in its research report dated March 25, 2025.

Suven Pharma Consolidated December 2024 Net Sales at Rs 307.15 crore, up 39.73% Y-o-Y

Stocks to Watch Today: Kotak Mahindra Bank, ICICI Bank, RailTel, Vakrangee, Medi Assist, RCF, Honasa Consumer, Muthoot Finance in focus on 13 February

Stocks To Watch, Feb 13: Stocks like Bharat Forge, Landmark Cars, Endurance Technologies, Balaji Amines, SKF India, IIFL Finance, Godawari Power & Ispat, PTC India, Suven Pharmaceuticals, SH Kelkar and Company, ITD Cementation India, Godrej Industries, Crompton Greaves Consumer Electricals, and Tata Power Company will be in focus on February 13.

Suven Pharma Consolidated September 2024 Net Sales at Rs 257.72 crore, up 11.54% Y-o-Y

Suven Pharma Standalone September 2024 Net Sales at Rs 236.06 crore, up 5.09% Y-o-Y

Stock Radar: ICICI Bank, Waaree Energies, IndiGo, Inox Wind, DLF, Lodha, Bandhan Bank, Coal India, ITD Cementation in focus on Monday

Reliance Industries, Yes Bank, Bank of Baroda, Macrotech Developers, Intellect Design Arena, Praj Industries, Texmaco Rail, Balkrishna Industries, Torrent Pharma, CreditAccess Grameen, and Aegis Logistics will also be in focus on October 28.

Suven Pharma Consolidated June 2024 Net Sales at Rs 230.69 crore, down 33.62% Y-o-Y

Suven Pharma Standalone June 2024 Net Sales at Rs 222.09 crore, down 35.44% Y-o-Y

Stock Radar: HCL Tech, DMart, IREDA, Piramal Pharma, Lupin in focus on Monday

5paisa Capital, Bhansali Engineering Polymers, Plastiblends India, Geojit Financial Services, Marico, Rail Vikas Nigam, Jupiter Wagons, Zomato and Alembic Pharmaceuticals will also be in focus on Monday.

Suven Pharma Consolidated March 2024 Net Sales at Rs 252.93 crore, down 31.52% Y-o-Y

Suven Pharma to acquire Hyderabad-based company, shares rise 3%

Suven Pharmaceuticals Share Price | The proposed transaction is subject to customary closing conditions.

Suven Pharma Standalone March 2024 Net Sales at Rs 243.52 crore, down 33.17% Y-o-Y

Suven-Cohance merged entity to have EBITDA margins in mid 30s: Management

In September 2023, the US-based private equity firm Advent acquired a controlling stake in Suven, expressing the intent to create a billion-dollar platform in the CDMO space.

Bulk deals: ICICI Prudential Life Insurance increases stake in Star Health and Allied Insurance

Foreign investor Apis Growth 6 sold 1.7 percent stake in Star Health and Allied Insurance

Sell Suven Pharmaceuticals; target of Rs 571: Geojit

Geojit is bearish on Suven Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 571 in its research report dated February 29, 2024.

Suven Pharma zooms 12% on merger with Cohance Lifesciences

Suven Pharmaceuticals Limited on February 29 announced a scheme of amalgamation for merger with Cohance Lifesciences Limited

Suven Pharma Consolidated December 2023 Net Sales at Rs 219.82 crore, down 37.86% Y-o-Y

Advent kickstarts merger process of Suven Pharma & Cohance; engages Kotak & Citi

Suven Pharmaceuticals is a listed CDMO and Cohance Lifesciences is an unlisted API and CDMO platform. Both are part of private equity firm Advent International's India portfolio.

Suven Pharma Standalone December 2023 Net Sales at Rs 212.83 crore, down 38.93% Y-o-Y

Suven Pharma Standalone September 2023 Net Sales at Rs 224.62 crore, down 19.32% Y-o-Y

Cabinet approves Rs 9,589 crore FDI in Suven Pharmaceuticals by Cyprus-based firm

The approval is for acquisition of up to 76.1 per cent shares of Suven Pharmaceuticals by Berhyanda by way of transfer of shares from existing promoter shareholders and public shareholders through mandatory open offer

Suven Pharma Consolidated June 2023 Net Sales at Rs 347.55 crore, up 2.58% Y-o-Y

Suven Pharma Standalone June 2023 Net Sales at Rs 344.03 crore, up 1.54% Y-o-Y

Suven Pharma Standalone March 2023 Net Sales at Rs 364.39 crore, up 0.15% Y-o-Y